Autologous Fat Grafting Techniques in Patients Undergoing Reconstructive Surgery
NCT ID: NCT02677012
Last Updated: 2020-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2016-02-04
2020-07-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Segmental Epidural Block for Feeding Jeujunostomy in Cancer Patients
NCT04376086
Anabolic Effects of Intraoperative Feeding in Reconstruction Surgery
NCT04266015
Perioperative Nutritional Optimization in Head and Neck Cancer Patients
NCT04449445
Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery
NCT05912257
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
NCT02792270
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Measure and compare the rate of fat processed, defined as the volume of fat processed per unit time associated with the use of three aforementioned adipose tissue processing techniques.
SECONDARY OBJECTIVES:
I. To measure total fat grafting time: time from initiation of fat harvesting to the end of fat injection.
II. To measure volume of fat processed: volume of fat obtained after fat processing.
III. To measure total operation room (OR) time: time from patient entry into the OR (or when the patient barcode is read on entering the OR) to the time at which the patient leaves the OR.
OUTLINE: Patients are randomized to 1 of 3 arms.
ARM I (REVOLVE TM): Patients undergo AFG reconstructive surgery comprising washing and low velocity spinning using a commercially available system that washes the lipoaspirate with lactated Ringer's solution separates non-fat material from the fat with gentle centrifugal force and suction.
ARM II (CYTORI PUREGRAT TM): Patients undergo AFG reconstructive surgery comprising gravity filtration using a commercially available system in which the lipoaspirate is rinsed with lactated Ringer's solution (RL) and the non-fat material is filtered through mesh.
ARM III (COLEMAN TECHNIQUE): Patients undergo AFG reconstructive surgery comprising standard centrifugation at 3200 revolutions per minute (rpm) for 3 minutes with the resulting oil and aqueous layers discarded.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm I (RESOLVE TM)
Patients undergo AFG reconstructive surgery comprising washing and low velocity spinning using a commercially available system that washes the lipoaspirate with lactated Ringer's solution separates non-fat material from the fat with gentle centrifugal force and suction.
Autologous Fat Graft
Undergo AFG using the RESOLVE TM technique
Reconstructive Surgery
Undergo reconstructive surgery
Arm II (Cytori PureGraft TM)
Patients undergo AFG reconstructive surgery comprising gravity filtration using a commercially available system in which the lipoaspirate is rinsed with lactated RL and the non-fat material is filtered through mesh.
Autologous Fat Graft
Undergo AFG using the Cytori PureGraft TM technique
Reconstructive Surgery
Undergo reconstructive surgery
Arm III (Coleman technique)
Patients undergo AFG reconstructive surgery comprising standard centrifugation at 3200 rpm for 3 minutes with the resulting oil and aqueous layers discarded.
Autologous Fat Graft
Undergo AFG using the Coleman technique
Reconstructive Surgery
Undergo reconstructive surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Autologous Fat Graft
Undergo AFG using the RESOLVE TM technique
Autologous Fat Graft
Undergo AFG using the Cytori PureGraft TM technique
Autologous Fat Graft
Undergo AFG using the Coleman technique
Reconstructive Surgery
Undergo reconstructive surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with body mass index (BMI) \> 20
* Estimated harvested fat volume \>= 100 cc
* Patients are willing and able to give consent
Exclusion Criteria
* Patients who are unable to provide consent
* Patients who are suspected or known to be pregnant
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Summer Hanson
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hanson SE, Garvey PB, Chang EI, Reece GP, Liu J, Baumann DP, Butler CE. A Randomized Prospective Time and Motion Comparison of Techniques to Process Autologous Fat Grafts. Plast Reconstr Surg. 2021 May 1;147(5):1035-1044. doi: 10.1097/PRS.0000000000007827.
Related Links
Access external resources that provide additional context or updates about the study.
MD Anderson Cancer Center Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2016-00346
Identifier Type: REGISTRY
Identifier Source: secondary_id
2015-0006
Identifier Type: OTHER
Identifier Source: secondary_id
2015-0006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.